Double maintains 1 strategies that include DYN - Dyne Therapeutics, Inc.
Yahoo
- FDA (CDER) Type C meeting held in May 2025 for DYNE-101 in DM1 and Dyne plans to provide a regulatory update following receipt of meeting minutes - - Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 initiated to support potential submission for U.S. Accelerated Approval in H1 2026 - - Registrational Expansion Cohort of DELIVER Trial of DYNE-251 in DMD fully enrolled to support potential submission for U.S. Accelerated Approval in early 2026 - WALTHAM, Mass., May 08, 2025 (GL
Finnhub
Dyne Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported net loss was USD 115.36 million compared to USD 65.65 million...
Yahoo
The company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.
Yahoo
- Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for late 2025 - WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that the European Commission (EC) has
Yahoo
Shares of gene therapy companies — including Sarepta Therapeutics — got a lift Monday after FDA's Marty Makary laid out his plans.
Yahoo
Vikram Ranade, PhD Vikram Ranade, PhD, Chief Business Officer (CBO) of Dyne Therapeutics Ranjan Batra, PhD Ranjan Batra, PhD, Chief Scientific Officer (CSO), of Dyne Therapeutics Oxana Beskrovnaya, PhD Oxana Beskrovnaya, PhD, Chief Innovation Officer (CIO), of Dyne Therapeutics - Vikram Ranade, PhD, appointed as chief business officer - - Ranjan Batra, PhD, appointed as chief scientific officer - - Oxana Beskrovnaya, PhD, transitioning to chief innovation officer - WALTHAM, Mass., April 15, 2025
Current Value
$11.771 Year Return
Current Value
$11.771 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -17.86% | $22.95B | +20.67% | 1.12% |
COR | -11.01% | $55.43B | +28.90% | 0.56% |
FMTO | -10.21% | $45.74M | -99.96% | 0.00% |
ED | -10.20% | $36.75B | +5.26% | 3.28% |
AEP | -7.60% | $54.28B | +9.80% | 3.61% |
BNED | -6.90% | $371.19M | -38.80% | 0.00% |
STG | -6.22% | $27.05M | -37.35% | 0.00% |
WBA | -6.11% | $9.67B | -39.04% | 6.69% |
CNC | -6.09% | $29.89B | -22.14% | 0.00% |
MOH | -5.91% | $17.02B | -8.99% | 0.00% |
RPRX | -5.71% | $13.96B | +18.79% | 2.55% |
CODI | -5.44% | $580.07M | -65.16% | 12.97% |
VZ | -5.40% | $183.32B | +8.02% | 6.21% |
MO | -5.13% | $97.80B | +26.35% | 6.94% |
NOC | -5.02% | $67.51B | -0.35% | 1.76% |
BPT | -4.83% | $13.70M | -73.66% | 0.00% |
UNH | -4.48% | $248.87B | -47.37% | 3.06% |
PGNY | -4.39% | $1.88B | -20.33% | 0.00% |
MKTX | -4.31% | $8.01B | -1.42% | 1.39% |
SHLS | -4.10% | $765.66M | -33.04% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RNA | 52.13% | $3.49B | +0.87% | 0.00% |
CRNX | 50.89% | $2.92B | -39.88% | 0.00% |
KYMR | 50.76% | $1.95B | -15.67% | 0.00% |
RVMD | 50.26% | $7.35B | +1.15% | 0.00% |
XNCR | 48.57% | $583.60M | -63.49% | 0.00% |
APGE | 47.50% | $2.42B | -24.39% | 0.00% |
ROIV | 47.03% | $7.68B | -5.70% | 0.00% |
RGNX | 46.88% | $433.39M | -46.03% | 0.00% |
RCKT | 46.73% | $724.54M | -71.26% | 0.00% |
NTLA | 46.28% | $836.43M | -69.14% | 0.00% |
STOK | 46.09% | $525.77M | -31.36% | 0.00% |
ATXS | 45.85% | $225.17M | -57.69% | 0.00% |
OCUL | 44.90% | $1.14B | +14.35% | 0.00% |
QTWO | 44.72% | $5.63B | +47.41% | 0.00% |
JEF | 44.05% | $11.02B | +12.97% | 2.65% |
IDYA | 44.01% | $1.52B | -58.32% | 0.00% |
ARWR | 43.63% | $2.12B | -38.64% | 0.00% |
RARE | 42.31% | $3.29B | -18.24% | 0.00% |
MSA | 41.99% | $6.23B | -16.22% | 1.29% |
ACLX | 41.96% | $3.22B | +10.72% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 57.20% | $4.85B | 0.35% |
GNOM | 52.95% | $40.65M | 0.5% |
IBB | 50.10% | $5.22B | 0.45% |
PTH | 49.60% | $96.56M | 0.6% |
PBE | 49.54% | $214.12M | 0.58% |
CPRJ | 49.11% | $48.43M | 0.69% |
IWC | 47.33% | $766.88M | 0.6% |
IWO | 46.53% | $11.36B | 0.24% |
KJUL | 46.10% | $113.35M | 0.79% |
VTWO | 44.91% | $12.07B | 0.07% |
IWM | 44.78% | $63.95B | 0.19% |
ARKG | 44.07% | $944.78M | 0.75% |
KJAN | 44.03% | $305.13M | 0.79% |
SCHA | 43.93% | $16.91B | 0.04% |
FBT | 43.73% | $994.71M | 0.56% |
BBH | 43.59% | $327.42M | 0.35% |
TMSL | 43.50% | $748.48M | 0.55% |
GSSC | 43.36% | $538.65M | 0.2% |
PINK | 43.28% | $131.52M | 0.5% |
IWMY | 43.19% | $109.62M | 1.02% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -36.59% | $109.64M | 0.85% |
BTAL | -32.57% | $361.41M | 1.43% |
TAIL | -31.65% | $140.49M | 0.59% |
FXY | -16.05% | $838.61M | 0.4% |
BILS | -10.60% | $3.96B | 0.1356% |
XHLF | -9.48% | $1.46B | 0.03% |
GBIL | -8.80% | $6.17B | 0.12% |
TFLO | -8.05% | $7.06B | 0.15% |
TBIL | -8.01% | $5.76B | 0.15% |
SGOV | -7.93% | $45.91B | 0.09% |
CTA | -6.86% | $1.05B | 0.76% |
BIL | -5.74% | $45.95B | 0.1356% |
FTSD | -5.38% | $212.46M | 0.25% |
JMST | -5.22% | $3.65B | 0.18% |
XONE | -5.14% | $603.24M | 0.03% |
CORN | -5.05% | $49.57M | 0.2% |
UNG | -4.19% | $371.83M | 1.06% |
XBIL | -4.18% | $782.40M | 0.15% |
IVOL | -4.12% | $353.94M | 1.02% |
BILZ | -4.08% | $876.85M | 0.14% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
USM | -0.04% | $5.19B | +38.83% | 0.00% |
AWK | -0.14% | $27.37B | +4.54% | 2.22% |
SOC | -0.15% | $2.51B | +100.14% | 0.00% |
KNOP | 0.16% | $226.71M | +23.32% | 1.57% |
VHC | -0.24% | $34.69M | +74.89% | 0.00% |
PSQH | -0.31% | $89.26M | -49.87% | 0.00% |
PEP | -0.34% | $180.30B | -28.19% | 4.14% |
RVP | 0.39% | $22.45M | -23.47% | 0.00% |
ALHC | 0.49% | $2.95B | +113.16% | 0.00% |
CL | -0.49% | $72.64B | -5.18% | 2.25% |
KR | 0.54% | $44.68B | +24.17% | 1.89% |
CVM | 0.56% | $19.46M | -83.48% | 0.00% |
DUK | 0.66% | $90.12B | +12.74% | 3.61% |
INSG | 0.87% | $116.01M | +20.22% | 0.00% |
AMT | 0.89% | $99.10B | +8.59% | 3.09% |
VSA | 0.91% | $7.04M | -49.24% | 0.00% |
GFI | -0.94% | $18.61B | +31.67% | 2.75% |
LRN | 0.95% | $6.69B | +118.03% | 0.00% |
G | -1.01% | $7.67B | +27.42% | 1.43% |
ZBH | -1.02% | $19.14B | -20.21% | 0.99% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPTL | -0.01% | $10.96B | 0.03% |
SCHQ | -0.01% | $829.57M | 0.03% |
STPZ | 0.05% | $446.46M | 0.2% |
UTEN | 0.06% | $192.72M | 0.15% |
VGLT | -0.07% | $9.57B | 0.04% |
AGGH | 0.08% | $309.35M | 0.29% |
IBTM | -0.11% | $313.33M | 0.07% |
CARY | -0.13% | $347.36M | 0.8% |
GOVI | 0.13% | $870.08M | 0.15% |
IBTP | 0.19% | $129.44M | 0.07% |
UUP | 0.25% | $292.27M | 0.77% |
FLGV | -0.29% | $976.63M | 0.09% |
TLT | -0.31% | $47.60B | 0.15% |
AGZ | -0.31% | $607.46M | 0.2% |
EDV | -0.39% | $3.32B | 0.05% |
WEAT | 0.42% | $115.83M | 0.28% |
BSCP | 0.44% | $3.49B | 0.1% |
IBTH | -0.46% | $1.53B | 0.07% |
IBTI | 0.48% | $995.39M | 0.07% |
IBMN | -0.48% | $446.12M | 0.18% |